PuSH - Publikationsserver des Helmholtz Zentrums München

Tong, J.* ; Davis, H.W.* ; Summer, S.* ; Benoit, S.C.* ; Haque, A.* ; Bidlingmaier, M.* ; Tschöp, M.H. ; D'Alessio, D.*

Acute administration of unacylated ghrelin has no effect on basal or stimulated insulin secretion in healthy humans.

Diabetes 63, 2309-2319 (2014)
DOI PMC
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Unacylated ghrelin (UAG) is the predominant ghrelin isoform in the circulation. Despite its inability to activate the classical ghrelin receptor, preclinical studies suggest that UAG may promote β-cell function. We hypothesized that UAG would oppose the effects of acylated ghrelin (AG) on insulin secretion and glucose tolerance. AG (1 µg/kg/h), UAG (4 µg/kg/h), combined AG+UAG, or saline were infused to 17 healthy subjects (9 M/8 F) on 4 occasions in randomized order. Ghrelin was infused for 30 min to achieve steady-state levels and continued through a 3-h IV glucose tolerance test. The acute insulin response to glucose (AIRg), insulin sensitivity index (SI), disposition index (DI), and IV glucose tolerance (kg) were compared for each subject during the 4 infusions. AG infusion raised fasting glucose levels but had no effect on fasting plasma insulin. Compared to the saline control both AG and AG+UAG decreased AIRg, but UAG alone had no effect. SI did not differ among the treatments. AG, but not UAG, reduced DI and kg and increased plasma growth hormone. UAG did not alter growth hormone, cortisol, glucagon or free fatty acid levels. UAG selectively decreased glucose and fructose consumption compared to the other treatments. In contrast to previous reports, acute administration of UAG does not have independent effects on glucose tolerance or β-cell function, and neither augments nor antagonizes the effects of AG.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Korrespondenzautor
Schlagwörter Beta-cell Function; Des-acyl Ghrelin; Hormone Secretagogue Receptor; Morbidly Obese Subjects; Growth-hormone; Glucose-tolerance; Nonacylated Ghrelin; Sensitivity; Endocrine; Appetite
ISSN (print) / ISBN 0012-1797
e-ISSN 1939-327X
Zeitschrift Diabetes
Quellenangaben Band: 63, Heft: 7, Seiten: 2309-2319 Artikelnummer: , Supplement: ,
Verlag American Diabetes Association
Verlagsort Alexandria, VA.
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Diabetes and Obesity (IDO)